Concepedia

Jens Stieler

JS

Statistics

Publications

31

Citations

2.9K

H-Index

25

Active since

2003

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Goethe University Frankfurt

Sana Klinikum Lichtenberg

Heidelberg University

University of Cologne

Jens Stieler is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and pancreatic cancer.

Publications per year

2003–2017

31

Publications

31

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Helmut Oettle, Hanno Riess, Jens Stieler et al. · Journal of Clinical Oncology · 2014 · 484 citations

Medicine, Oncology, Pharmacology +13

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

Uwe Pelzer, Ingo Schwaner, Jens Stieler et al. · European Journal of Cancer · 2011 · 380 citations

Medicine, Oncology, Chemotherapy +10

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Marianne Sinn, Marcus Bahra, Torsten Liersch et al. · Journal of Clinical Oncology · 2017 · 296 citations

Medicine, Oncology, Pharmacotherapy +13

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Uwe Pelzer, Bernhard Opitz, G. Deutschinoff et al. · Journal of Clinical Oncology · 2015 · 266 citations

Medicine, Pharmacology, Pharmacotherapy +14

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

M. Sinn, Carsten Denkert, Jana K. Striefler et al. · British Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Oncology, Pathology +17

1–5 of 31